C
Founded in 1999, Cyprotex (www.cyprotex.com) has grown to become an industry leader in in vitro and in silico ADME-Tox. The company, with sites in the UK and USA, was acquired by Evotec (www.evotec.com) in 2016. The Evotec Group offer expert support from early discovery through to clinical development. * High-throughput ADME screening * Customised ADME assays * In silico ADME predictive modeling * In vitro toxicology
Investor insights
Funding rounds participated in
$2.7M sweet spot round size
Investor type
Public Company
Basic info
Industry
Research Services
Sectors
Research Services
Date founded
1999
Funding rounds raised
Total raised
$2.7M
from investors over 1 rounds
C
Cyprotex raised $2.7M on September 17, 2010